A Systematic Review on the Diagnosis of Pediatric Bacterial Pneumonia: When Gold Is Bronze by Lynch, Tim et al.
A Systematic Review on the Diagnosis of Pediatric
Bacterial Pneumonia: When Gold Is Bronze
Tim Lynch
1, Liza Bialy
2*, James D. Kellner
3, Martin H. Osmond




2, David W. Johnson
3
1Department of Pediatrics, Children’s Hospital, University of Western Ontario, London, Ontario, Canada, 2Department of Pediatrics, University of Alberta, Edmonton,
Alberta, Canada, 3Department of Pediatrics and Physiology and Pharmacology, University of Calgary and Alberta Children’s Hospital, Calgary, Alberta, Canada, 4Clinical
Research Unit, Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada
Abstract
Background: In developing countries, pneumonia is one of the leading causes of death in children under five years of age
and hence timely and accurate diagnosis is critical. In North America, pneumonia is also a common source of childhood
morbidity and occasionally mortality. Clinicians traditionally have used the chest radiograph as the gold standard in the
diagnosis of pneumonia, but they are becoming increasingly aware that it is not ideal. Numerous studies have shown that
chest radiography findings lack precision in defining the etiology of childhood pneumonia. There is no single test that
reliably distinguishes bacterial from non-bacterial causes. These factors have resulted in clinicians historically using a
combination of physical signs and chest radiographs as a ‘gold standard’, though this combination of tests has been shown
to be imperfect for diagnosis and assigning treatment. The objectives of this systematic review are to: 1) identify and
categorize studies that have used single or multiple tests as a gold standard for assessing accuracy of other tests, and 2)
given the ‘gold standard’ used, determine the accuracy of these other tests for diagnosing childhood bacterial pneumonia.
Methods and Findings: Search strategies were developed using a combination of subject headings and keywords adapted
for 18 electronic bibliographic databases from inception to May 2008. Published studies were included if they: 1) included
children one month to 18 years of age, 2) provided sufficient data regarding diagnostic accuracy to construct a 262 table,
and 3) assessed the accuracy of one or more index tests as compared with other test(s) used as a ‘gold standard’. The
literature search revealed 5,989 references of which 256 were screened for inclusion, resulting in 25 studies that satisfied all
inclusion criteria. The studies examined a range of bacterium types and assessed the accuracy of several combinations of
diagnostic tests. Eleven different gold standards were studied in the 25 included studies. Criterion validity was calculated for
fourteen different index tests using eleven different gold standards. The most common gold standard utilized was blood
culture tests used in six studies. Fourteen different tests were measured as index tests. PCT was the most common
measured in five studies each with a different gold standard.
Conclusions: We have found that studies assessing the diagnostic accuracy of clinical, radiological, and laboratory tests for
bacterial childhood pneumonia have used a heterogeneous group of gold standards, and found, at least in part because of
this, that index tests have widely different accuracies. These findings highlight the need for identifying a widely accepted
gold standard for diagnosis of bacterial pneumonia in children.
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Introduction
In developing countries, pneumonia is one of the leading causes
of death in children under five years of age and hence timely and
accurate diagnosis is critical [1]. In North America, pneumonia is
also a common source of childhood morbidity and occasionally
mortality [2]. A study from Israel has also shown that there can be
significant economic burdens to children and families dealing with
community acquired pneumonia, as well as significant reduction in
their quality of life [3].
Viruses, atypical, and typical bacteria cause the vast majority of
childhood pneumonia [2–4] The distribution of pathogens varies
with age and clinical setting. Atypical bacterial microorganisms,
such as Mycoplasma and Chlamydia usually occur in children
between the ages of five and 15 years [5–7], while the incidence of
viral infections typically decreases with age [5]. In hospitalized
children, the most frequently diagnosed bacteria are the typical
pathogens, such as Streptococcus pneumoniae [5]. It can be
difficult to identify whether the cause of pneumonia in a given
patient is bacterial or nonbacterial [8,9]. Classic signs unique to
bacterial or nonbacterial pneumonia can be helpful in coming to a
diagnosis [9]. However, these signs and symptoms are often
subjective, and are ultimately imprecise at determining whether
antibiotics are truly warranted [4].
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bacterial pneumonia has not yet been developed [2,5,8]. Often
the most readily available means of diagnosing pneumonia are
through observations of physical signs and radiological evi-
dence. Diagnostic guidelines have been developed by the World
Health Organization for pneumonia and these are generally
used in developing countries or in the absence of quick access to
laboratory tests [10]. Other diagnostic tests have been used with
variable rates of accuracy, such as chest radiographs, laboratory
tests (white blood cell count [WBC]) with differential, C-reactive
protein (CRP), erythrocyte sedimentation rate (ESR) [8,9],
blood cultures and serology [8], and lung puncture [8,9]. The
ideal surrogate marker for bacterial pneumonia should be
accurate, minimally invasive, and readily available. To date,
there is no such gold standard that a physician can rely on to
confidently diagnose and subsequently treat bacterial pneumo-
nia [2].
Clinicians traditionally have used the chest radiograph as the
gold standard in the diagnosis of pneumonia, but they are
becoming increasingly aware that it is not ideal. Numerous studies
have shown that chest radiography findings lack accuracy in
defining the etiology of childhood pneumonia [2,11,12]. There is
no single test that reliably distinguishes bacterial from non-
bacterial causes [4]. These factors have resulted in clinicians
historically using a combination of physical signs and chest
radiographs as a ‘gold standard’, though this combination of tests
has been shown to be imperfect for diagnosis and assigning
treatment [5,13].
The objectives of this systematic review are to: 1) identify and
categorize studies that have used single or multiple tests as a gold
standard for assessing accuracy of other tests, and 2) given the
‘gold standard’ used, determine the accuracy of these other tests
for diagnosing childhood bacterial pneumonia.
Methods
This review has been carried out using methods defined for
rigorous systematic reviews [14,15]. The aim was to use these
guidelines and other methodological criteria [16–18] to produce a
systematic review that is comprehensive and summarizes the data
collected (see PRISMA Checklist S1).
Ethics Statement
Data for this study was acquired through previously published
work, no patient or hospital data was accessed. Therefore, written
consent and institutional ethical review was not required for this
research.
Search Strategy and Selection Criteria
Search strategies were developed using a combination of subject
headings and keywords, including: ‘‘pneumonia’’, ‘‘bacteria’’,
‘‘community acquired pneumonia’’, ‘‘lower respiratory tract
infection’’, ‘‘pneumococcal’’, ‘‘diagnosis’’, ‘‘accuracy’’, ‘‘sensitivi-
ty’’, ‘‘reliability’’, ‘‘specificity’’, ‘‘false/true positive/negative’’,
‘‘predictive value’’, ‘‘observer variation’’, ‘‘likelihood functions/
ratios’’, ‘‘ROC curve’’, ‘‘receiver operating characteristic’’,
‘‘child’’, ‘‘adolescent’’, ‘‘infant’’, ‘‘minors’’, ‘‘pediatrics’’, ‘‘nurser-
ies’’, ‘‘youth’’, ‘‘nursery’’, ‘‘nurseries’’, ‘‘toddler’’, ‘‘clinical trials’’,
‘‘cohort studies’’, ‘‘case-control studies’’, ‘‘comparative’’, ‘‘evalua-
tion studies’’, ‘‘prospective’’, ‘‘retrospective’’, and ‘‘follow up’’.
These keywords were adapted for each of the 18 electronic
bibliographic databases from inception to May 2008 (see Table 1
for full listing). Extended systematic search methods (e.g., hand
searches of non-indexed journals, reference list tracking, and
contact with experts) were also used (See Table 2 for full listing).
No language or date restrictions were applied to the search
strategy.
Table 1. Databases and Trials Registers Included in Search.
Source/Database Name Source/Year
MEDLINEH (Ovid; 1950–April 2008)
Ovid MedlineH In-Process & Other Non-Indexed Citations (up to April 2008)
Cochrane Central Register of Controlled Trials (Ovid; 1
st Quarter, 2008)
Cochrane Database of Systematic Reviews (Ovid; 1
st Quarter, 2008)
Database of Abstracts of Reviews of Effects (DARE) (Ovid; 1
st Quarter 2008)
EMBASEH (1988–April 2008)
CINAHL (EBSCOhost; 1937–April 2008)
HealthSTAR (Ovid; 1966–April 2008)
Global Health (Ovid; 1987–April 2008)
Pascal (Ovid; 1987–April 2008)
BIOSIS PreviewsH (via Web of ScienceH ; 1969–April 2008)
Science Citation Index Expanded
TM and Social Science Citation IndexH (via Web of ScienceH; 1900–April 2008)
PubMed (1966 to October 2006)
Current Controlled Trials, ClinicalTrials.gov, Clinical Trials in Cardiology http://www.controlled-trials.com/, http://clinicaltrials.gov/, www2.umdnj.
edu/,shindler/trials/trials_a.html
National Research Register www.update-software.com/National/
Computer Retrieval of Information on Scientific Projects (CRISP) http://crisp.cit.nih.gov
Australian Clinical Trials Registry www.actr.org.au
MEDION www.mediondatabase.nl
NLM (National Library of Medicine) Gateway, BioMed Central, and OCLC PapersFirst were searched for identification of meeting abstracts
doi:10.1371/journal.pone.0011989.t001
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reviewers (LB and RL). The primary reason for exclusion of
articles was documented. Scientific-based publications were
included if they: (1) involved children between the ages of 1
month and 18 years of age, (2) provided diagnostic accuracy data
to construct a 262 table, and (3) compared a gold standard and
index test that were both used to make a diagnosis of bacterial
pneumonia taken to include both typical and atypical pneumo-
nia. Gold standard and index test categories included radio-
graphic, hematologic, immunologic, microbiologic, virologic,
and clinical variables (signs and symptoms). Due to the lack
of a defined gold standard that can reliably differentiate bacterial
from non-bacterial pneumonia, all combinations of tests
assessing the diagnostic accuracy of bacterial pneumonia were
included. To assess study quality the Quality Assessment of
Studies of Diagnostic Accuracy included in Systematic Reviews
(QUADAS) was applied by two independent reviewers (LB and
RL) [19,20].
Table 2. Grey Literature Databases/Websites Searched.
Website URL
Agency for Healthcare Research and Quality (AHRQ) http://ahcpr.gov
American Academy of Allergy Asthma & Immunology http://www.aaaai.org/members/annual_meeting
American Academy of Pediatrics http://www.aap.org/
American College of Chest Physicians http://www.chestnet.org/
American Thoracic Society http://www.thoracic.org/sections/meetings-and-courses/index.
html
Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID) http://www.espid.net/
Annual Meeting of the Infectious Diseases Society of America (IDSA) 2001–2005 http://www.idsociety.org/
Asian Pacific Society of Respirology, 11th APSR Congress http://www.apsresp.org/
Australian Clinical Trials Registry http://www.actr.org.au/
Basal Institute of Clinical Epidemiology http://www.bice.ch/engl/research.htm
Basel Institute for Clinical Epidemiology http://www.bice.ch/engl/home.htm
Bayes Library of diagnostic Studies and Reviews http://www.ispm.ch
British Thoracic Society http://www.brit-thoracic.org.uk/
Conference on Global Lung Health http://www.worldlunghealth.org/
Database of Promoting Health Effectiveness Reviews (DoPHER) http://eppi.ioe.ac.uk.cms
Database of Systematic Reviews in Clinical Chemistry and Laboratory Medicine http://www.ckcjl-mb.nl/ifcc/
European Congress of Clinical Microbiology and Infectious Diseases 2001–2005 http://www.akm.cc/eccmid2001-2005/
European Respiratory Society http://dev.ersnet.org/
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) http://www.escmid.org/
GreyLit Report http://nyam.org/library/grey.shtml
Guidelines International Network http://www.g-i-n.net
Health Evidence http://hebs.cf.ac.uk
Health Technology Assessment Database http://agatha.york.ac.uk/htahp.htm
HTAi vortal Health Technology Assessment International http://www.htai.org/vortal/
Infectious Diseases Society of America http://www.idsociety.org/
International Pediatric Association http://www.ipa-world.org/meetings/meetings.htm
International Society for Infectious Diseases http://www.isid.org/
Interscience Conference Antimicrobial Agents and Chemotherapy http://www.icaac.org
LWWOnline: The Pediatric Infectious Disease Journal http://pidj.com
MEDION http://www.mediondatabase.nl/
National Institute of Allergy and Infectious Diseases (NIAID) http://www3.niaid.nih.gov
New York Academy of Medicine Library, Grey Literature Collection http://www.nyam.org/library/grey.shtml
Oxford Childhood Infection Study http://www.dphpc.ox.ac.uk/oxcis/
Pediatric Academic Societies Archive 2000–2005 http://www.abstracts2view.com/pasall
Pediatric Critical Care Medicine http://www.pccmjournal.com
The Society for Clinical Trials http://www.sctweb.org/
US Department of Health and Human Services, Centers for Disease Control and Prevention http://www.cdc.gov/ncidod/
World Health Organization (WHO) http://search.who.int
World Congress on Pediatric Critical Care http://www.wfpiccs.org/
doi:10.1371/journal.pone.0011989.t002
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Data was extracted by one reviewer and checked for accuracy
and completeness by a second reviewer. Any disagreements were
resolved through discussion with the clinical leaders.
Data analysis was based on a published methodological review
[21]. The primary outcome is accuracy of the screening test (i.e.,
sensitivity, specificity, positive and/or negative predictive values
with corresponding 95% confidence intervals using standard
formulas) [22]. For each individual study, we reconstructed a
standard 262 table and if multiple studies had used the same index
test and gold standard weighted averages of the sensitivities,
specificities or predictive values were computed.
Results
The literature search revealed 5,989 references of which 256
were screened for inclusion. As shown in Figure 1 this resulted in
25 studies that satisfied all inclusion criteria.
Study Characteristics
The studies examined a range of bacterium types and assessed
the accuracy of several combinations of diagnostic tests. Detailed
characteristics of each study appear in Tables S1 and S2. These
studies were published between 1986 and 2007 from 12 different
countries. The majority of included studies originated from higher
income countries (Australia, Italy, Spain, France, United States,
Switzerland, Japan, and Finland), as defined by The World Bank,
with 7 studies from the middle to low income category (China/
Taiwan, Argentina, Brazil, and Bangladesh) [23]. All subjects were
children between the ages of one month and 17 years, with a mean
age of 6.56 years (based on 14 studies reporting a mean or median
age). Gender was evenly distributed as specified in 12 of 25 studies
(52.3% male). The majority of the studies collected patient data
prospectively (21/25) from a single site (24/25). Eleven studies
examined atypical species of bacterial pneumonia, six looked at
typical bacteria, and seven combined both atypical and typical
varieties. One study defined what they studied only as ‘bacterial
pneumonia’.
To be included in our review studies needed to clearly describe
both the index and gold standards used. A specific gold standard
was not defined a priori, therefore all combinations of index tests
and gold standards were included, provided the studies met all
inclusion criteria. We broadly categorized the types of diagnostic
tests (both gold and index) as radiographic, hematologic,
immunologic, microbiologic, virologic, or clinical variables
(signs/symptoms) for ease of comparison. From the 25 included
articles, we ended up with 23 distinct combinations of these
categories. As a result of the wide range of testing modalities it was
not possible to combine studies or compute weighted accuracy
data (see Table S3 for individual study tests and data). Therefore
we conducted a qualitative review of this literature and non-
numerically summarized the major findings. Results for each of
the studies can be found in Table S3. All 25 articles were assessed
using the QUADAS tool and the scores ranged from 8 to 14, with
an average score of 10.44 (see Table S4 for quality assessment of
individual studies).
Categorization of Gold Standards
Eleven different gold standards were studied in the 25 included
studies. The most common gold standard utilized was blood
Figure 1. PRISMA flowchart of study selection, retrieval, and inclusion.
doi:10.1371/journal.pone.0011989.g001
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the criterion validity of nine different index tests, including the
measurement of signs/symptoms, hematologic, chest radiograph,
nested Polymerase Chain Reaction (PCR), procalcitonin (PCT),
CRP, latex agglutination, immunochromatographic membrane
assay, and lung aspirate. Sensitivities ranged from 10% for
the lung aspirate as an index test to 100% with urine latex
agglutination for Hib as an index test. Specificities ranged from
63.2% for the chest radiograph as an index test to100% with
nested PCR as an index test.
Five studies [25,30–33] used a chest radiograph either alone or
with other variables as the gold standard, measuring the validity of
seven index tests. These index tests included: PCT with three cutoff
points, WBC count, CRP, serology by complement fixation in 2
studies, latex particle agglutination, and nested PCR. With the chest
radiograph as the gold standard, sensitivities ranged from 14.3%
(radiographexhibitedairtrapping)to77.8%(PCT.0.5 ng/ml)and
specificities ranged from 34.8% (PCT.0.5 ng/ml) to 100% (nested
PCR).
The one study [28] that used pleural fluid cultures as the gold
standard revealed that the immunochromatographic membrane
assay for urinary pneumococcal antigen detection had a sensitivity
of 90.9% and a specificity of 68.8%. Other gold standards utilized
in the studies included: hematologic [34], microbiologic [35–39],
hematologic/immunologic [40], serology [41,42], immunologic
[43–46], and clinical signs and symptoms [47].
Categorization of Index Tests
Fourteen different tests were measured as index tests. PCT was
the most common measured in five studies [26,30,36,42,46], each
with a different gold standard. There were as many as four separate
cutoff points set for the PCT levels utilized. The sensitivity of PCT
ranged from 40% when 0.5 ng/dl was set as the cutoff point and
chest radiography was used as a gold standard to 95.4% in two
studies witha cutoff above 0.5 ng/dl when blood cultures were used
as the gold standard. For all studies its sensitivity decreased and its
specificity increased as the cutoff points were raised.
An additional four studies used clinical variables, PCR, and
CRP as their index tests. PCR was used as the index test
[25,34,44,45] with six different gold standards. Sensitivities ranged
from 36.4% with complement fixation (Mycoplasma pneumonia)
to 95.7% with Mycoplasma serology. Specificities ranged from
79.7% with mycoplasma serology to 100% with positive blood
cultures or clinical and radiological evidence of pneumonia.
Clinical variables [24,39–41] and CRP [36,39,46,48] each
demonstrated broad ranges in sensitivities and specificities for the
array of clinical variables and the different cutoff points for CRP
measured. The chest radiograph’s accuracy was measured as an
index test in four [24,35,40,47] of the studies. Its sensitivity peaked
at 75% with a range of 0–75% depending on the radiological
definition assigned while its specificity ranged from 50 to 100%.
Four studies [24,39,42,48] utilized the total WBC count as an
index test with three ranges being utilized. Sensitivities ranged
from 20% to 65.1% and specificities ranged from 53.1% to79.3%
when the total WBC count was above 15 000 (X10
6/l).
Other index tests utilized in the studies included: interleukin-6
at 3 different levels [36,42,46], immunologic [28,36–38], micro-
biologic [27,31–33,38], virologic [32,43], hematologic [39], and
lung aspirate [29].
Discussion
Diagnostic testing provides physicians with information about
the likelihood of certain diseases. Ideally these diagnostic tests have
been validated against an agreed-upon gold/reference standard.
The objective of the Standards for Reporting of Diagnostic
Accuracy (STARD) initiative [49] is to improve the accuracy and
completeness of reporting of studies of diagnostic accuracy. They
defined the gold/reference standard to be ‘‘the best available
method for establishing the presence or absence of the condition of
interest.’’ They further add that ‘‘the reference standard can be a
single method, or a combination of methods, to establish the
presence of the target condition. It can include laboratory tests,
imaging tests, and pathology, but also dedicated clinical follow-up
of subjects.’’ This systematic review has demonstrated that
diagnostic tests used for pediatric pneumonia have not been truly
validated and there is little agreement as to what tests should be
used as a gold standard. It is, therefore, difficult to recommend any
of the reference standards used in the reviewed studies as ‘‘the best
available method’’ given these limitations.
This review underscores the fundamental problem with
diagnosing pneumonia in children when there is no proven and
accurate gold standard. Since the standards used to define
pneumonia are variable and inconsistent it is difficult to know
whether the criterion validity of these diagnostic tests is accurate or
not. A problem of ‘circularity’ exists for which there is no easy
solution.
An additional problem is that the included studies did not all
focus on the same type of bacterial disease. Eleven studies dealt
with atypical pneumonia, six with typical pneumonia, and seven
studied both typical and atypical pneumonia. And even within
those studies which focused on the same type of bacterial etiology
(e.g. pneumococcal pneumonia), each study defined the disease
differently. For example, a patient with a positive blood culture for
pneumococcus is likely clinically different from a patient with a
negative blood culture.
One challenging aspect is that most of the studies were
performed in high income countries with only seven studies
performed in low income countries. This is contrast to the disease
burden, where most of the mortality from pneumonia happens in
low income countries. Future research should try to redress this
imbalance.
Categorization of Gold Standards
Of the eleven different gold standards utilized, the blood culture
and the chest radiograph were the most common tests. Chest
radiography was utilized in five studies as the gold standard while
in three other studies it was measured as an index test. When it
was employed as an index test its sensitivity was generally low
while its specificity was generally high. This sub-par performance
as an index test illustrates that the use of chest radiography as a
gold standard is potentially flawed. The use of ten other gold
standards for twenty of the studies highlights that there is much
disagreement amongst researchers worldwide whether the chest
radiograph should be utilized as a gold standard or an index test.
In most academic emergency departments, a chest radiograph is
considered the standard of care and is readily obtained for
pediatric patients with the clinical suspicion of bacterial pneumo-
nia. Clinically similar patients with potential ambulatory pneu-
monia presenting to a clinic or private office are less likely to
undergo chest radiography.
From a clinical perspective, the blood culture is somewhat
invasive and the results are generally not available for several
hours. Further only a relatively small percentage of patients with
bacterial pneumonia yield a positive blood culture (which results in
low sensitivity), and now with the widespread use of conjugate
pneumoococcal vaccine, the yield of blood cultures would be even
less.
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Fourteen different index tests’ criterion validity was measured.
The heterogeneity of the different studies was further illustrated
when the results of the different index tests were compared.
Though the overall criterion validity of PCR was reasonably
consistent, most other index tests (e.g. clinical variables, total WBC
count, interleukin-6 and CRP) had highly variable accuracy.
As an example, in one study of PCT used as an index test, Don
[30] concluded, in contrast to other studies, that serum PCT could
not reliably distinguish bacterial from non-bacterial pneumonia.
However, Don et al. [30] utilized as gold standard a chest
radiograph that was inconclusive in 34% of their patients. This
example illustrates that, given the diversity of the diagnostic
methods used, current evidence is potentially inaccurate and
highly misleading.
There is a critical need for experts in childhood pneumonia to
develop an accepted gold standard. While it would be optimal for
such a test to be cheap and readily available to practicing
clinicians, the development of a more complex gold standard for
use in research studies would be a major advance. As suggested in
the STARD initiative,[49] one approach for developing a more
complex standard is to use a combination of methods including
imaging tests, laboratory tests available both immediately and long
after the fact, and clinical features obtained not only at
presentation but on dedicated follow-up subjects. The problem
then becomes how each of these individual items should be
weighted relative to the others. Given the highly variable results
we found for most reference tests, a fixed algorithmic approach to
combining methods is not possible. Alternatively an expert panel
could use standard consensus methods to weigh the results of chest
x-ray, standard and specialized laboratory tests, bacterial and viral
diagnostic tests and clinical course of patients to classify patients as
bacterial or non-bacterial.[50–51] The development of such a gold
standard would greatly enhance and aid the evaluation of
diagnostic tests for their accuracy in the future.
Although we conducted a comprehensive electronic and hand
search of the literature, as well as verification of all extracted data
this review is not without limitations. The main limitation of this
review is the inability to include Latin American databases such as
the Latin American and Caribbean Health Sciences Literature
(LILACS) and Scientific Electronic Library Online (SciELO) as
part of the electronic search strategy. At the onset of this review we
were unable to identify a clinical expert fluent in Spanish to
participate in the identification of search terms and in the
screening, inclusion/exclusion, and extraction phases of the
systematic review. African and Asian databases were also not
included for similar reasons. We acknowledge this as a limiting
factor of this review but with the breadth of other databases
searched we do not believe this has altered the results.
In conclusion, we have found that studies assessing the
diagnostic accuracy of clinical, radiological, and laboratory tests
for bacterial childhood pneumonia have used a heterogeneous
group of gold standards, and found, at least in part because of this,
that index tests have widely different accuracies. These findings
highlight the need for identifying a widely accepted gold standard
for diagnosis of bacterial pneumonia in children.
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